Active Pharmaceutical Ingredient (API): 10.56% Lidocaine base.

Mechanism of Action: Reversible blockade of voltage-gated sodium (Na+) channels. Inhibits neuronal membrane depolarization, suppressing C-fiber and A-delta nerve impulse transmission.

Clinical Data: Yields 95.2% reduction in nociceptive pain signals during intradermal injections (e.g., hyaluronic acid, PLLA) and laser ablation. Onset time: 15-20 minutes. Anesthetic duration: 45-60 minutes.

pH Level: 5.8 – 6.3 (Epidermal-optimized)

Base Formula: Hypoallergenic, non-vasoconstrictive

Origin: Maypharm Facility #0732

Certification:

Storage: 15-25°C (59-77°F)

1. Prep: Sanitize target area with alcohol-free cleanser.

2. Dose: Apply 2.0 mg/cm² (approx. 2-3mm uniform layer).

3. Occlusion: Apply surgical film to accelerate absorption.

4. Removal: Wipe completely with sterile gauze at 25±5 minutes.

⚠ MAXIMUM DOSAGE: Do not exceed 4.5g per 100cm² per 24-hour period.

Restricted to licensed clinical practitioners. Contraindicated for patients with known hypersensitivity to amide-type local anesthetics or a clinical history of congenital/idiopathic methemoglobinemia. Monitor systemic absorption rates on compromised epidermal barriers.